Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Acute Lymphoblastic Leukemia
15%
BCP-ALL
15%
Childhood Acute Lymphoblastic Leukemia
100%
Clinical Response
7%
Favorable Prognosis
7%
Glucocorticoid Sensitivity
7%
Good Responders
7%
Immunophenotyping
7%
In Vitro Resistance
15%
Intrathecal Injection
7%
Leukemia Patients
15%
Methotrexate
7%
Monotherapy
15%
Multidrug Chemotherapy
7%
Newly Diagnosed
7%
Non-associated
7%
Peanut Agglutinin
100%
Poor Responders
7%
Prednisolone
53%
ProB
7%
Prognostic Factors
7%
Prognostic Significance
100%
Relative Risk
7%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
46%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
B Cell
15%
Chemotherapy
7%
Dexamethasone
15%
Glucocorticoid
7%
Immunophenotyping
7%
In Vitro
15%
Intrathecal Drug Administration
7%
Lanoteplase
7%
Methotrexate
7%
Monotherapy
15%
Peanut Agglutinin
100%
Precursor
15%
Prednisolone
53%
Prognostic Factor
7%
Prospective Study
7%
Neuroscience
B Cell
15%
Dexamethasone
15%
Glucocorticoid
7%
Immunophenotyping
7%
In Vitro
15%
Intrathecal
7%
Lanoteplase
7%
Methotrexate
7%
Peanut Agglutinin
100%
Prednisolone
53%
T Cell
46%
Biochemistry, Genetics and Molecular Biology
B Cell
15%
Dexamethasone
15%
Glucocorticoid
7%
Immunophenotyping
7%
Methotrexate
7%
Peanut Agglutinin
100%
Precursor
15%
Prednisolone
53%
Prospective Study
7%
T Cell
46%
Immunology and Microbiology
B Cell
15%
Dexamethasone
15%
Glucocorticoid
7%
Methotrexate
7%
Peanut Agglutinin
100%
Precursor
15%
Prednisolone
53%
T Cell
46%